Quality Featured Articles

  1. Avoiding Launch Delays With A Proactive Tech Transfer Strategy 5/12/2026

    Commercial success comes from treating tech transfer as a strategic collaboration. Flexible processes, early supply chain planning, and partnerships protect timelines and drive long‑term performance.

  2. How Equipment Choices Influence Scientific Velocity In Development 5/11/2026

    As drug modalities grow more complex, speed depends on smarter decisions. See how bioprocessing equipment choices play a larger role in enabling momentum than many teams realize.

  3. Why Cost-Sensitive Innovation Matters In Biopharmaceutical Development 5/11/2026

    Drug development demands scientific depth and operational precision. Explore how efficiency can be built into discovery and manufacturing, as well as why cost‑sensitive innovation is crucial.

  4. [Video] Get It Right with The Gemba 5/8/2026

    The idea of the Gemba walk originated after World War II in Japan, specifically in relation to automotive production at Toyota. The word can be translated to “the real or actual place,” referring to where the work takes place—in the case of pharma or automobiles, on the factory floor.

  5. What Validation Really Means For Visual Inspection Programs 5/8/2026

    True validation requires documented proof that inspectors and methods consistently catch defects. Move beyond static SOPs to a state of continuous, data-backed compliance and audit readiness.

  6. Enhancing Safety In Drug Substance Synthesis: A Smart Approach To Chemical Design 5/6/2026

    Discover how safety‑by‑design principles in chemical synthesis help control exothermic reactions, reduce scale‑up risk, and enable safer, more reliable manufacturing of complex drug substances.

  7. How Rheology Ensures Effective Quality Control 5/1/2026

    Rheology connects formulation science to manufacturing reality. By tracking how drugs flow and respond to stress, teams can prevent batch variability and protect dosage performance.

  8. Causal Mechanism And Effect Analysis (CMEA): FMEA's Simpler, Effective Alternative 5/1/2026

    This article describes causal mechanism and effect analysis (CMEA) as an alternative to failure mode and effect analysis (FMEA) for analyzing and managing the industry’s risks.

  9. Making Mental Health Drugs: Promising Therapies And Manufacturing Challenges 4/30/2026

    Psychedelic therapies have shown promise in treating mental health disorders, but it will take close collaboration and cooperation of all related agencies and manufacturers to make this promise a reality.

  10. A 5-Step Foundation For Early CQV Involvement 4/28/2026

    All too often, a project’s issues show up in CQV, and it is there that blame is pointed. However, these issues start earlier and are entirely avoidable with proper planning.